ACR: Inebilizumab Reduces Risk for Flares in IgG4-Related Disease

TUESDAY, Nov. 19, 2024-- For patients with immunoglobulin G (IgG)4-related disease, inebilizumab reduces the risk for flares and increases the likelihood of flare-free complete remission, according to a study published online Nov. 14 in the New...